Methylation-associated silencing of the Thrombospondin-1 gene in human neuroblastoma

Qi Wei Yang, Shuqing Liu, Yufeng Tian, Helen R. Salwen, Alexandre Chlenski, Joanna Weinstein, Susan L. Cohn

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

Tumor angiogenesis, a major requirement for tumor outgrowth and metastasis, is regulated by pro- and antiangiogenic factors. Methylation-associated inactivation of the angiogenesis inhibitor thrombospondin-1 (TSP-1) has been observed recently in some adult tumors. To investigate the role of TSP-1 in pediatric cancer, we examined its pattern of expression and mechanisms of regulation in neuroblastoma (NB). TSP-1 was silenced in a subset of undifferentiated, advanced-stage tumors and NB cell lines. In contrast, most localized tumors expressed this angiogenesis inhibitor, and a significant correlation between morphological evidence of neuroblast differentiation and TSP-1 expression was observed. Luciferase assays demonstrated the presence of nuclear factors required for TSP-1 transcription in both TSP-1-positive and -negative cell lines, but no correlation between TSP-1 promoter activity and the level of TSP-1 mRNA expression was seen. Our studies indicate that the transcriptional silencing of TSP-1 was caused by methylation. TSP-1 promoter methylation was detected in all of the NB cell lines lacking TSP-1 mRNA and in 37% of the NB clinical tumors analyzed. Furthermore, treatment with the demethylating agent, 5-Aza-2′-deoxycytidine (5-Aza-dC), restored TSP-1 expression in NB cell lines. Disrupting methylation with 5-Aza-dC also led to significant inhibition of NB in vivo and re-expression of TSP-1 in a subset of NB xenografts. These results suggest that 5-Aza-dC inhibits NB growth by augmenting the expression of TSP-1 along with other genes that suppress tumor growth. Demethylating agents may prove to be effective candidates for the treatment of children with NB.

Original languageEnglish (US)
Pages (from-to)6299-6310
Number of pages12
JournalCancer Research
Volume63
Issue number19
StatePublished - Oct 1 2003

Fingerprint

Thrombospondin 1
Neuroblastoma
Methylation
decitabine
Genes
Neoplasms
Angiogenesis Inhibitors
Cell Line
Messenger RNA
Growth
Tumor Cell Line
Luciferases
Heterografts

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Yang, Q. W., Liu, S., Tian, Y., Salwen, H. R., Chlenski, A., Weinstein, J., & Cohn, S. L. (2003). Methylation-associated silencing of the Thrombospondin-1 gene in human neuroblastoma. Cancer Research, 63(19), 6299-6310.

Methylation-associated silencing of the Thrombospondin-1 gene in human neuroblastoma. / Yang, Qi Wei; Liu, Shuqing; Tian, Yufeng; Salwen, Helen R.; Chlenski, Alexandre; Weinstein, Joanna; Cohn, Susan L.

In: Cancer Research, Vol. 63, No. 19, 01.10.2003, p. 6299-6310.

Research output: Contribution to journalArticle

Yang, QW, Liu, S, Tian, Y, Salwen, HR, Chlenski, A, Weinstein, J & Cohn, SL 2003, 'Methylation-associated silencing of the Thrombospondin-1 gene in human neuroblastoma', Cancer Research, vol. 63, no. 19, pp. 6299-6310.
Yang QW, Liu S, Tian Y, Salwen HR, Chlenski A, Weinstein J et al. Methylation-associated silencing of the Thrombospondin-1 gene in human neuroblastoma. Cancer Research. 2003 Oct 1;63(19):6299-6310.
Yang, Qi Wei ; Liu, Shuqing ; Tian, Yufeng ; Salwen, Helen R. ; Chlenski, Alexandre ; Weinstein, Joanna ; Cohn, Susan L. / Methylation-associated silencing of the Thrombospondin-1 gene in human neuroblastoma. In: Cancer Research. 2003 ; Vol. 63, No. 19. pp. 6299-6310.
@article{88d9569ef07b430a823a29ab77da3f4c,
title = "Methylation-associated silencing of the Thrombospondin-1 gene in human neuroblastoma",
abstract = "Tumor angiogenesis, a major requirement for tumor outgrowth and metastasis, is regulated by pro- and antiangiogenic factors. Methylation-associated inactivation of the angiogenesis inhibitor thrombospondin-1 (TSP-1) has been observed recently in some adult tumors. To investigate the role of TSP-1 in pediatric cancer, we examined its pattern of expression and mechanisms of regulation in neuroblastoma (NB). TSP-1 was silenced in a subset of undifferentiated, advanced-stage tumors and NB cell lines. In contrast, most localized tumors expressed this angiogenesis inhibitor, and a significant correlation between morphological evidence of neuroblast differentiation and TSP-1 expression was observed. Luciferase assays demonstrated the presence of nuclear factors required for TSP-1 transcription in both TSP-1-positive and -negative cell lines, but no correlation between TSP-1 promoter activity and the level of TSP-1 mRNA expression was seen. Our studies indicate that the transcriptional silencing of TSP-1 was caused by methylation. TSP-1 promoter methylation was detected in all of the NB cell lines lacking TSP-1 mRNA and in 37{\%} of the NB clinical tumors analyzed. Furthermore, treatment with the demethylating agent, 5-Aza-2′-deoxycytidine (5-Aza-dC), restored TSP-1 expression in NB cell lines. Disrupting methylation with 5-Aza-dC also led to significant inhibition of NB in vivo and re-expression of TSP-1 in a subset of NB xenografts. These results suggest that 5-Aza-dC inhibits NB growth by augmenting the expression of TSP-1 along with other genes that suppress tumor growth. Demethylating agents may prove to be effective candidates for the treatment of children with NB.",
author = "Yang, {Qi Wei} and Shuqing Liu and Yufeng Tian and Salwen, {Helen R.} and Alexandre Chlenski and Joanna Weinstein and Cohn, {Susan L.}",
year = "2003",
month = "10",
day = "1",
language = "English (US)",
volume = "63",
pages = "6299--6310",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "19",

}

TY - JOUR

T1 - Methylation-associated silencing of the Thrombospondin-1 gene in human neuroblastoma

AU - Yang, Qi Wei

AU - Liu, Shuqing

AU - Tian, Yufeng

AU - Salwen, Helen R.

AU - Chlenski, Alexandre

AU - Weinstein, Joanna

AU - Cohn, Susan L.

PY - 2003/10/1

Y1 - 2003/10/1

N2 - Tumor angiogenesis, a major requirement for tumor outgrowth and metastasis, is regulated by pro- and antiangiogenic factors. Methylation-associated inactivation of the angiogenesis inhibitor thrombospondin-1 (TSP-1) has been observed recently in some adult tumors. To investigate the role of TSP-1 in pediatric cancer, we examined its pattern of expression and mechanisms of regulation in neuroblastoma (NB). TSP-1 was silenced in a subset of undifferentiated, advanced-stage tumors and NB cell lines. In contrast, most localized tumors expressed this angiogenesis inhibitor, and a significant correlation between morphological evidence of neuroblast differentiation and TSP-1 expression was observed. Luciferase assays demonstrated the presence of nuclear factors required for TSP-1 transcription in both TSP-1-positive and -negative cell lines, but no correlation between TSP-1 promoter activity and the level of TSP-1 mRNA expression was seen. Our studies indicate that the transcriptional silencing of TSP-1 was caused by methylation. TSP-1 promoter methylation was detected in all of the NB cell lines lacking TSP-1 mRNA and in 37% of the NB clinical tumors analyzed. Furthermore, treatment with the demethylating agent, 5-Aza-2′-deoxycytidine (5-Aza-dC), restored TSP-1 expression in NB cell lines. Disrupting methylation with 5-Aza-dC also led to significant inhibition of NB in vivo and re-expression of TSP-1 in a subset of NB xenografts. These results suggest that 5-Aza-dC inhibits NB growth by augmenting the expression of TSP-1 along with other genes that suppress tumor growth. Demethylating agents may prove to be effective candidates for the treatment of children with NB.

AB - Tumor angiogenesis, a major requirement for tumor outgrowth and metastasis, is regulated by pro- and antiangiogenic factors. Methylation-associated inactivation of the angiogenesis inhibitor thrombospondin-1 (TSP-1) has been observed recently in some adult tumors. To investigate the role of TSP-1 in pediatric cancer, we examined its pattern of expression and mechanisms of regulation in neuroblastoma (NB). TSP-1 was silenced in a subset of undifferentiated, advanced-stage tumors and NB cell lines. In contrast, most localized tumors expressed this angiogenesis inhibitor, and a significant correlation between morphological evidence of neuroblast differentiation and TSP-1 expression was observed. Luciferase assays demonstrated the presence of nuclear factors required for TSP-1 transcription in both TSP-1-positive and -negative cell lines, but no correlation between TSP-1 promoter activity and the level of TSP-1 mRNA expression was seen. Our studies indicate that the transcriptional silencing of TSP-1 was caused by methylation. TSP-1 promoter methylation was detected in all of the NB cell lines lacking TSP-1 mRNA and in 37% of the NB clinical tumors analyzed. Furthermore, treatment with the demethylating agent, 5-Aza-2′-deoxycytidine (5-Aza-dC), restored TSP-1 expression in NB cell lines. Disrupting methylation with 5-Aza-dC also led to significant inhibition of NB in vivo and re-expression of TSP-1 in a subset of NB xenografts. These results suggest that 5-Aza-dC inhibits NB growth by augmenting the expression of TSP-1 along with other genes that suppress tumor growth. Demethylating agents may prove to be effective candidates for the treatment of children with NB.

UR - http://www.scopus.com/inward/record.url?scp=0141885092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141885092&partnerID=8YFLogxK

M3 - Article

C2 - 14559817

AN - SCOPUS:0141885092

VL - 63

SP - 6299

EP - 6310

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 19

ER -